+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells



Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells



Biochemical Pharmacology 65(9): 1419-1425



Due to the size, glycosylation, and location in the plasma membrane of the sialomucin complex Muc4, which has been implicated in ErbB2 signaling, in the repression of apoptosis and cell adhesion, and in tumor metastasis, studies were initiated to determine whether its presence could influence cell sensitivity to anticancer drugs. Growth inhibition assays using melanoma cell lines that either express the glycoprotein (Muc4(+)) or do not (Muc4(-)) showed that Muc4 renders cells resistant to taxol, doxorubicin, vinblastine, rhodamine 123, and 2-deoxyglucose. When treated with various concentrations of doxorubicin, Muc4(+) cells were blocked less frequently in G(2) and underwent less DNA fragmentation (apoptosis and/or necrosis) than Muc4(-) cells. All of the drugs tested (except for 2-deoxyglucose) are well recognized by P-glycoprotein-mediated multidrug resistance 1 (MDR1) and to a lesser degree by multidrug resistance related protein 1 (MRP1) transporters. Therefore, transporter gene expression in these cells was assayed. Surprisingly, Muc4(+) cells expressed lower levels of both transporter genes than Muc4(-) cells. Moreover, rhodamine 123 was retained more highly in the Muc4(+) than in the Muc4(-) cells, demonstrating that these transporters are functional. Overall, these results indicate that although Muc4(+) cells express less MDR1 and MRP1, they are more resistant to drugs recognized by these transporters.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011022857

Download citation: RISBibTeXText

PMID: 12732353

DOI: 10.1016/s0006-2952(03)00086-8


Related references

Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis. Plos one 8(8): E69611, 2013

Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells. International Journal of Urology 4(6): 583-590, 1997

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. Journal of Urology 170(4 Pt 1): 1383-1387, 2003

P-glycoprotein , multidrug-resistance related protein and lung resistance protein multidrug resistance phenotypes in peripheral blood and bone marrow. Proceedings of the American Association for Cancer Research Annual Meeting 38: 388, 1997

The Pipecolinate Derivatives VX-710 and VX-853 Are Effective Modulators of Drug Efflux Mediated by the Multidrug Resistance Proteins P-Glycoprotein, Multidrug Resistance Protein and Breast Cancer Resistance Protein in Acute Myeloid Leukemia Cells. Blood 100(11): Abstract No 245, 2002

High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(4): 705-714, 2010

Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. Journal of Pharmacology and Experimental Therapeutics 314(3): 1059-1067, 2005

Tc-99m-Tetrofosmin is transported by the multidrug resistance P-glycoprotein and the multidrug resistance-associated protein , but not related gene family members. Journal of Nuclear Medicine 40(5 Suppl. ): 230P, 1999

Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts. Leukemia Research 23(5): 467-475, 1999

Functional determination of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts. Proceedings of the American Association for Cancer Research Annual Meeting 39: 213, 1998

S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells. Biochemical Pharmacology 56(4): 497-502, 1998

Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives. Biological and Pharmaceutical Bulletin 31(6): 1258-1264, 2008

Multidrug resistance-associated protein 3 and multidrug resistance p-glycoprotein MDR1 are strongly expressed in reactive ductules in human liver diseases. Hepatology 34(4 Pt 2): 479A, 2001

Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes. European Journal of Biochemistry 252(1): 140-146, 1998

Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells. Oncology Letters 12(2): 1569-1574, 2016